Скачать или смотреть Dr Patel on Toxicities Associated With Immunotherapy-Based Combinations in NSCLC

Sandip P. Patel, MD, a professor of medicine in the Department of Medicine at the University of California, San Diego (UCSD) and a medical oncologist at the UCSD Moores Cancer Center, discussed toxicities to be aware of when using immunotherapy-based combination regimens in patients with advanced non–small cell lung cancer (NSCLC). He also highlighted the current role of antibody-drug conjugates in the NSCLC treatment paradigm, as well as ways this class of agents may evolve in the future.

See our site for more exclusive insights from the 2025 Bridging the Gaps in Lung Cancer meeting! https://www.onclive.com/bridging-the-...

Website: https://www.onclive.com
Twitter:   / onclive  
Facebook:   / onclive  
LinkedIn:   / onclive